| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |